In pre-specified analyses for time to first occurrence of MACE, there were 44 MACE-5 (all-cause death, heart attack, stroke, heart failure event, or coronary revascularization ) events observed in participants randomized to retatrutide (pooled 9 mg and 12 mg) and 52 events observed in those randomized to placebo, resulting in a hazard ratio of 0.82 (95.0% CI: 0.55 to 1.22)
Its consumer friendly for many low-acuity uses
In particular, incretin-based therapies and sodium-glucose co-transporter 2 (SGLT2) inhibitors have attracted increasing interest not only for their glucose-lowering effects, but also for their broader metabolic, renal, and cardiovascular benefits
Integr Med Insights
They work by binding to receptors in the body and mimicking hormones that are naturally produced in the gut, by doing this they decrease the speed at which food is digested creating a sense of fullness, and also attaching to receptors that stop food cravings
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis